These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1649260)

  • 21. Immunoelectronmicroscopical demonstration of major histocompatibility class II antigen: expression on endothelial and perivascular cells but not Schwann cells in human neuropathy.
    Atkinson PF; Perry ME; Hall SM; Hughes RA
    Neuropathol Appl Neurobiol; 1993 Feb; 19(1):22-30. PubMed ID: 7682673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies.
    Meyer Zu Horste G; Heidenreich H; Lehmann HC; Ferrone S; Hartung HP; Wiendl H; Kieseier BC
    Glia; 2010 Jan; 58(1):80-92. PubMed ID: 19544394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy.
    Leppert D; Hughes P; Huber S; Erne B; Grygar C; Said G; Miller KM; Steck AJ; Probst A; Fuhr P
    Neurology; 1999 Jul; 53(1):62-70. PubMed ID: 10408538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy.
    Krendel DA; Parks HP; Anthony DC; St Clair MB; Graham DG
    Muscle Nerve; 1989 Apr; 12(4):257-64. PubMed ID: 2770778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies.
    Younger DS; Rosoklija G; Hays AP; Trojaborg W; Latov N
    Muscle Nerve; 1996 Jun; 19(6):722-7. PubMed ID: 8609922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.
    Molenaar DS; Vermeulen M; de Haan R
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):84-9. PubMed ID: 9436733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schwann cell GFAP expression increases in axonal neuropathies.
    Mancardi GL; Cadoni A; Tabaton M; Schenone A; Zicca A; De Martini I; Bianchini D; Damiani G; Zaccheo D
    J Neurol Sci; 1991 Apr; 102(2):177-83. PubMed ID: 1649261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of chronic inflammatory demyelinating polyneuropathy.
    Rotta FT; Sussman AT; Bradley WG; Ram Ayyar D; Sharma KR; Shebert RT
    J Neurol Sci; 2000 Feb; 173(2):129-39. PubMed ID: 10675657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies.
    Tamura N; Kuwabara S; Misawa S; Mori M; Nakata M; Hattori T
    Clin Neurophysiol; 2005 Oct; 116(10):2330-3. PubMed ID: 16122982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP).
    Rizzuto N; Morbin M; Cavallaro T; Ferrari S; Fallahi M; Galiazzo Rizzuto S
    Acta Neuropathol; 1998 Dec; 96(6):603-9. PubMed ID: 9845290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glial fibrillary acidic protein as a marker of axonal damage in chronic neuropathies.
    Notturno F; Capasso M; DeLauretis A; Carpo M; Uncini A
    Muscle Nerve; 2009 Jul; 40(1):50-4. PubMed ID: 19533665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies.
    Lindenlaub T; Sommer C
    Acta Neuropathol; 2003 Jun; 105(6):593-602. PubMed ID: 12734666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies.
    Hu W; Janke A; Ortler S; Hartung HP; Leder C; Kieseier BC; Wiendl H
    Neurology; 2007 Jan; 68(4):277-82. PubMed ID: 17242332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; van den Berg LH; Franssen H; Giesbergen PC; Flach HZ; van Putten AM; Veldman H; Wokke JH
    Brain; 2001 Dec; 124(Pt 12):2427-38. PubMed ID: 11701597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neuroinflammatory role of Schwann cells in disease.
    Ydens E; Lornet G; Smits V; Goethals S; Timmerman V; Janssens S
    Neurobiol Dis; 2013 Jul; 55():95-103. PubMed ID: 23523637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Incidence of diabetic neuropathy which fulfills electrophysiologic criteria of CIDP].
    Miyasaki H; Hasegawa O; Mori I; Matsumoto S; Arita T
    No To Shinkei; 1999 May; 51(5):415-8. PubMed ID: 10396747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immunocompetence of Schwann cells.
    Meyer zu Hörste G; Hu W; Hartung HP; Lehmann HC; Kieseier BC
    Muscle Nerve; 2008 Jan; 37(1):3-13. PubMed ID: 17823955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immune-mediated neuropathies: indications and value of nerve biopsy].
    Verschueren A
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S58-60. PubMed ID: 18087231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.